Oncology Institute (TOIIW) Asset Utilization Ratio (2021 - 2026)

Oncology Institute has reported Asset Utilization Ratio for 6 years, with the latest figure at 3.28 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 36.93% year-over-year to 3.28; the trailing twelve-month figure through Mar 2026 stood at 3.28 (up 36.93% YoY), and the FY2025 full-year result was 2.98, up 44.67% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 3.28, up from 3.06 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 3.28 in Q1 2026, with the low at 0.93 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 1.85 across 5 years, with a median of 1.66 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio slipped 1.1% — and 2023, when it surged 63.82%.
• Oncology Institute's Asset Utilization Ratio stood at 0.93 in 2022, then surged by 63.82% to 1.52 in 2023, then jumped by 47.43% to 2.24 in 2024, then soared by 36.98% to 3.06 in 2025, then increased by 7.06% to 3.28 in 2026.
• The last three Asset Utilization Ratio figures came in at 3.28 (Q1 2026), 3.06 (Q4 2025), and 2.85 (Q3 2025), per Business Quant data.